Dopamine receptor expression on human T- and B-lymphocytes, monocytes, neutrophils, eosinophils and NK cells: A flow cytometric study

Journal of Neuroimmunology

Volumn 132, Issue 1-2, 2002, Pages 34-40

  McKenna, F ^a   McLaughlin, P J ^a   Lewis, B J ^a   Sibbring, G C ^a   Cummerson, J A ^a   Bowen Jones, D ^a   Moots, R J ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Dopamine receptor; Flow cytometry; Human leukocytes; Neuroimmunology

Indexed keywords

ANTIBODY; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE 5 RECEPTOR; DOPAMINE RECEPTOR;

ARTICLE; B LYMPHOCYTE; CELL POPULATION; CONTROLLED STUDY; EOSINOPHIL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LEUKOCYTE; MONOCYTE; NATURAL KILLER CELL; NEUTROPHIL; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; T LYMPHOCYTE;

B-LYMPHOCYTES; EOSINOPHILS; FLOW CYTOMETRY; HUMANS; KILLER CELLS, NATURAL; MONOCYTES; NEUTROPHILS; RECEPTORS, DOPAMINE; T-LYMPHOCYTES;

EID: 0036848282     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(02)00280-1     Document Type: Article

References (44)

1. Amenta F., Bronzetti E., Felici L., Ricci A., Tayebati S.K. Dopamine D2-like receptors on human peripheral blood lymphocytes: a radioligand binding assay and immunocytochemical study. J. Auton. Pharmacol. 19:1999;151-159.
2. 5 receptor in peripheral blood lymphocytes of migraineurs: a marker for migraine? Neurosci. Lett. 207:1996;73-76.
3. Barili P., Bronzetti E., Felici L., Ferrante F., Ricci A., Zaccheo D., Amenta F. Age-dependent changes in the expression of dopamine receptor subtypes in human peripheral blood lymphocytes. J. Neuroimmunol. 71:1996;45-50.
4. Bergquist J., Silberring J. Identification of catecholamines in the immune system by electrospray ionization mass spectrometry. Rapid Commun. Mass Spectrom. 12:1998;683-688.
5. Bergquist J., Ohlsson B., Tarkowski A. Nuclear factor-kappa B is involved in the catecholaminergic suppression of immunocompetent cells. Ann. N.Y. Acad. Sci. 917:2000;281-289.
6. 4 receptor mRNA in circulating human lymphocytes using nested polymerase chain reaction. J. Neuroimmunol. 71:1996;139-144.
7. 2 dopaminergic antagonists on mouse T and B lymphocyte proliferation and interleukin production in vitro. Immunopharmacol. Immunotoxicol. 10:1988;501-512.
8. 2 dopamine receptors. Mol. Pharmacol. 45:1994;51-60.
9. Cosentino M., Bombelli R., Ferrari M., Marino F., Rasini E., Maestroni G.J., Conti A., Boveri M., Lecchini S., Frigo G. HPLC-ED measurement of endogenous catecholamines in human immune cells and hematopoietic cell lines. Life Sci. 68:2000;283-295.
10. Garza H.H. Jr., Mayo S., Bowen W.D., DeCosta B.R., Carr D.J. Characterization of a (+)-azidophenazocine-sensitive sigma receptor on splenic lymphocytes. J. Immunol. 151:1993;4672-4680.
11. Gingrich J.A., Caron M.G. Recent advances in the molecular biology of dopamine receptors. Annu. Rev. Neurosci. 16:1993;299-321.
12. 3H]spiperone by lymphocytes in schizophrenics and their first-degree relatives: a limited vulnerability marker? J. Psychiatr. Res. 26:1992;77-84.
13. Hasko G., Szabo C., Nemeth Z.H., Deitch E.A. Dopamine suppresses IL-12 p40 production by lipopolysaccharide-stimulated macrophages via a beta-adrenoceptor-mediated mechanism. J. Neuroimmunol. 122:2002;34-39.
14. Josefsson E., Bergquist J., Ekman R., Tarkowski A. Catecholamines are synthesized by mouse lymphocytes and regulate function of these cells by induction of apoptosis. Immunology. 88:1996;140-146.
15. Lachowicz J.E., Sibley D.R. Molecular characteristics of mammalian dopamine receptors. Pharmacol. Toxicol. 81:1997;105-113.
16. 2 receptors on normal human T cells, and activates beta1 integrin function. Eur. J. Immunol. 31:2001;3504-3512.
17. Liu Y., Wolfe S.A. Jr. Haloperidol and spiperone potentiate murine splenic B cell proliferation. Immunopharmacology. 34:1996;147-159.
18. McCarty M.F. Upregulation of lymphocyte apoptosis as a strategy for preventing and treating autoimmune disorders: a role for whole-food vegan diets, fish oil and dopamine agonists. Med. Hypotheses. 57:2001;258-275.
19. Mena M.A., Garcia de Yebenes M.J., Tabernero C., Casarejos M.J., Pardo B., Garcia de Yebenes J. Effects of calcium antagonists on the dopamine system. Clin. Neuropharmacol. 18:1995;410-426.
20. Missale C., Nash S.R., Robinson S.W., Jaber M., Caron M.G. Dopamine receptors: from structure to function. Physiol. Rev. 78:1998;189-225.
21. Mizruchin A., Gold I., Krasnov I., Livshitz G., Shahin R., Kook A.I. Comparison of the effects of dopaminergic and serotonergic activity in the CNS on the activity of the immune system. J. Neuroimmunol. 101:1999;201-204.
22. Moots R.J., Al-Saffar Z., Hutchinson D., Golding S.P., Young S.P., Bacon P.A., McLaughlin P.J. Old drug, new tricks: haloperidol inhibits secretion of proinflammatory cytokines. Ann. Rheum. Dis. 58:1999;585-587.
23. Morkawa K., Oseko F., Morikawa S. Immunosuppressive property of bromocriptine on human B lymphocyte function in vitro. Clin. Exp. Immunol. 93:1993;200-205.
24. Moulding D.A., Akgul C., Derouet M., White M.R., Edwards S.W. BCL-2 family expression in human neutrophils during delayed and accelerated apoptosis. J. Leukoc. Biol. 70:2001;783-792.
25. 3 dopamine receptor gene and a novel variant transcript generated by alternative splicing in human peripheral blood lymphocytes. Biochem. Biophys. Res. Commun. 194:1993;368-374.
26. 3 receptor in a transfected NG 108-15 neuroblastoma-glioma hybrid cell line. Eur. J. Pharmacol. 268:1994;129-139.
27. 3 receptor in peripheral mononuclear cells of essential hypertensives. Hypertension. 30:1997;1566-1571.
28. 3H]7-OH-DPAT: a combined radioligand binding assay and immunochemical study. J. Neuroimmunol. 92:1998;191-195.
29. Ricci A., Bronzetti E., Mignini F., Tayebati S.K., Zaccheo D., Amenta F. Dopamine D1-like receptor subtypes in human peripheral blood lymphocytes. J. Neuroimmunol. 96:1999;234-240.
30. Rocheville M., Lange D.C., Kumar U., Patel S.C., Patel R.C., Patel Y.C. Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity. Science. 288:2000;154-157.
31. 1 dopamine receptors: an in vitro analysis. Int. J. Immunopharmacol. 1:2001;1363-1374.
32. Santambrogio L., Lipartiti M., Bruni A., Dal Toso R. Dopamine receptors on human T- and B-lymphocytes. J. Neuroimmunol. 45:1993;113-119.
33. Sawatzky D.A., Kingham P.J., Court E., Kumaravel B., Fryer A.D., Jacoby D.B., McLean W.G., Costello R.W. Eosinophil adhesion to cholinergic nerves via ICAM-1 and VCAM-1 and associated eosinophil degranulation. Am. J. Physiol., Lung Cell. Mol. Physiol. 282:2002;L1279-L1288.
34. 3 dopamine receptor heterodimers exhibit unique functional properties. J. Biol. Chem. 276:2001;30308-30314.
35. Seeman P., Van Tol H.H. Dopamine receptor pharmacology. Trends Pharmacol. Sci. 15:1994;264-270.
36. Sibley D.R., Monsma F.J. Jr. Molecular biology of dopamine receptors. Trends Pharmacol. Sci. 13:1992;61-69.
37. Sookhai S., Wang J.H., McCourt M., O'Connell D., Redmond H.P. Dopamine induces neutrophil apoptosis through a dopamine D-1 receptor-independent mechanism. Surgery. 126:1999;314-322.
38. 4 dopamine receptors revealed in transfected neuronal cell lines. Proc. Natl. Acad. Sci. U. S. A. 91:1994;649-653.
39. 5 dopamine receptor gene and transcribe the two pseudogenes. FEBS Lett. 314:1992;23-25.
40. Tarazona R., Gonzalez-Garcia A., Zamzami N., Marchetti P., Frechin N., Gonzalo J.A., Ruiz-Gayo M., van Rooijen N., Martinez C., Kroemer G. Chlorpromazine amplifies macrophage-dependent IL-10 production in vivo. J. Immunol. 154:1995;861-870.
41. Tsao C.W., Lin Y.S., Cheng J.T. Inhibition of immune cell proliferation with haloperidol and relationship of tyrosine hydroxylase expression to immune cell growth. Life Sci. 62:1998;PL335-PL344.
42. Vallone D.A., Picetti R., Borrelli E. Structure and function of dopamine receptors. Neurosci. Biobehav. Rev. 24:2000;125-132.
43. Vile J.M., Strange P.G. D2-like dopamine receptors are not detectable on human peripheral blood lymphocytes. Biol. Psychiatry. 40:1996;881-885.
44. Weihe E., Nohr D., Michel S., Muller S., Zentel H.J., Fink T., Krekel J. Molecular anatomy of the neuro-immune connection. Int. J. Neurosci. 59:1991;1-23.